Evidence map›Paper›PMID 19389425›Full record

ArticlePlasmid2009

A novel short hairpin RNA (shRNA) expression system promotes Sox9-dependent gene silencing.

James R Gilbert, Christopher S Adams, Irving M Shapiro, Noreen J Hickok

Abstract read
In one paragraph

Article in Plasmid, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

James R GilbertDepartment of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA 19107, USA. jrg111@jefferson.edu
Christopher S Adams
Irving M Shapiro
Noreen J Hickok
Thomas Jefferson University · US

Funding

Smart Substrates for a New Generation of ImplantsR01AR051303 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI SHAPIRO, IRVING M · 2005 to 2009
$3.1M
BONE GROWTH IN DENTAL, CRANIAL AND SKELETAL TISSUESR01DE010875 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI SHAPIRO, IRVING M · 1994 to 2006
$2.4M
TRAINING IN MOLECULAR RHEUMATOLOGY &ORTHOPEDICST32AR007583 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI JIMENEZ, SERGIO A · 1994 to 2008
$1.3M
CRANIOFACIAL DEVELOPMENT: METABOLIC CONTROL OF APOPTOSISR01DE013319 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI SHAPIRO, IRVING M · 1999 to 2003
$1.1M
NIAMS NIH HHS R01 AR051303NIAMS NIH HHS T32 AR007583NIDCR NIH HHS R01 DE010875NIDCR NIH HHS R01 DE013319
6 · The paper itself

Abstract

Cartilage development and function are dependent on a temporally integrated program of gene expression. With the advent of RNA interference (RNAi), artificial control of these complex programs becomes a possibility, limited only by the ability to regulate and express the RNAi. Using existing methods for production of RNAi's, we have constructed a plasmid-based short hairpin RNA (shRNA) expression system under control of the human pol III H1 promoter and supplemented this promoter with DNA binding sites for the cartilage-specific transcription factor Sox9. The resulting shRNA expression system displays robust, Sox9-dependent gene silencing. Dependence on Sox9 expression was confirmed by electrophoretic mobility shift assays. The ability of the system to regulate heterologously expressed Sox9 was demonstrated by Western blot, as a function of both Sox9 to shRNA ratio, as well as time from transfection. This novel expression system supports auto-regulatory gene silencing, providing a tissue-specific feedback mechanism for temporal control of gene expression. Its applications for both basic mechanistic studies and therapeutic purposes should facilitate the design and implementation of innovative tissue engineering strategies.

Indexed as

Gene SilencingGenetic TechniquesNucleic Acid ConformationCell LineGene Expression RegulationGreen Fluorescent ProteinsHumansPlasmidsPromoter Regions, GeneticRNA, Small InterferingSOX9 Transcription FactorTime FactorsGreen Fluorescent ProteinsRNA, Small InterferingSOX9 Transcription Factor

Identifiers

PMID19389425
PMCPMC2760318
OpenAlexW2091231797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.